KB Financial Group to Debut "Physical AI Care Service" at AI Expo

The First Humanoid Robot-Based Senior Care Service in Korea's Financial Sector

Unveiling the 'Physical AI Senior Care Service'

Led by Age Tech Lab... Pioneering Korea's Age-Tech Industry

KB Financial Group announced on April 30 that it will unveil the country’s first senior care-focused “Physical AI Care Service” utilizing humanoid robots in the financial sector at 'AI EXPO KOREA 2026,' which will be held at COEX in Seoul for three days from June 6 to June 8.

KB Financial Group is developing a physical AI-based senior care service model in collaboration with GENON, a generative AI specialist, to respond to the super-aged society and accelerate the growth of the domestic age-tech industry.

At this exhibition, the company will present features such as emotional care through conversation and emotional interaction with seniors, daily care management including medication and schedule reminders, as well as periodic health checks and monitoring for health management. In addition, scenarios involving physical interaction will be demonstrated, such as using the humanoid robot’s precision manipulator (hand) to deliver medication or assist in patient rehabilitation.

Since 2012, KB Financial Group has provided a comprehensive senior total care solution that encompasses both financial and non-financial services, uniting the capabilities of its affiliates around its senior-focused brand “KB Golden Life.”

In January this year, the company established the “Age Tech Lab,” a state-of-the-art technology experience and research space for seniors, at the KB Life Tower in Yeoksam-dong, Seoul. Through collaboration with innovative companies, KB Financial Group is supporting the introduction and pilot testing of the latest devices and services.

KB Financial Group plans to use the Age Tech Lab as a base to apply physical AI to senior care, verifying the potential of future-oriented care services that can address the rapidly increasing demand for care due to population aging. The company also plans to accumulate empirical data to prove the effectiveness in care settings and lead the domestic age-tech industry by paving the way for commercialization.

This content was produced with the assistance of AI translation services.